JPWO2019213668A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019213668A5
JPWO2019213668A5 JP2020561751A JP2020561751A JPWO2019213668A5 JP WO2019213668 A5 JPWO2019213668 A5 JP WO2019213668A5 JP 2020561751 A JP2020561751 A JP 2020561751A JP 2020561751 A JP2020561751 A JP 2020561751A JP WO2019213668 A5 JPWO2019213668 A5 JP WO2019213668A5
Authority
JP
Japan
Prior art keywords
epitope
seq
aavx
derived
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020561751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523702A (ja
JP2021523702A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030955 external-priority patent/WO2019213668A1/en
Publication of JP2021523702A publication Critical patent/JP2021523702A/ja
Publication of JP2021523702A5 publication Critical patent/JP2021523702A5/ja
Publication of JPWO2019213668A5 publication Critical patent/JPWO2019213668A5/ja
Priority to JP2024079802A priority Critical patent/JP2024119818A/ja
Pending legal-status Critical Current

Links

JP2020561751A 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ Pending JP2021523702A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024079802A JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862667360P 2018-05-04 2018-05-04
US62/667,360 2018-05-04
PCT/US2019/030955 WO2019213668A1 (en) 2018-05-04 2019-05-06 Human anti-aav2 capsid polyclonal antibody epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024079802A Division JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Publications (3)

Publication Number Publication Date
JP2021523702A JP2021523702A (ja) 2021-09-09
JP2021523702A5 JP2021523702A5 (https=) 2022-05-16
JPWO2019213668A5 true JPWO2019213668A5 (https=) 2022-05-16

Family

ID=68386753

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020561751A Pending JP2021523702A (ja) 2018-05-04 2019-05-06 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024079802A Pending JP2024119818A (ja) 2018-05-04 2024-05-15 ヒト抗ａａｖ２カプシドポリクローナル抗体エピトープ

Country Status (5)

Country Link
US (1) US20210292370A1 (https=)
EP (1) EP3799568A4 (https=)
JP (2) JP2021523702A (https=)
CN (1) CN112351787A (https=)
WO (1) WO2019213668A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3861010A1 (en) 2018-10-02 2021-08-11 Voyager Therapeutics, Inc. Redirection of tropism of aav capsids
IL293658A (en) * 2019-12-10 2022-08-01 Homology Medicines Inc Adeno-associated virus preparations and a method of using them
US12209251B2 (en) 2020-05-05 2025-01-28 The University Of North Carolina At Chapel Hill Modified adeno-associated virus 5 capsids and uses thereof
CN116096734A (zh) 2020-05-13 2023-05-09 沃雅戈治疗公司 Aav衣壳的向性的重定向
CN113583112B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav特异性抗体及其应用
CN113999861B (zh) * 2021-09-08 2024-03-15 三峡大学 腺相关病毒衣壳蛋白保守区多克隆抗体的制备方法及应用
MX2024004936A (es) 2021-11-02 2024-05-08 Voyager Therapeutics Inc Variantes de capsides de aav y sus usos.
CN114685651B (zh) * 2022-04-15 2023-07-11 三峡大学 一种特异识别aav9衣壳蛋白的多克隆抗体及制备方法
WO2025100417A1 (ja) * 2023-11-06 2025-05-15 株式会社ダイセル Ａａｖのフルカプシドに対するアフィニティポリペプチド

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749492B2 (en) * 2001-01-05 2010-07-06 Nationwide Children's Hospital, Inc. AAV vectors and methods
EP1828390B1 (en) * 2004-12-15 2012-06-13 The University Of North Carolina At Chapel Hill Chimeric vectors
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
DK2675902T3 (da) * 2011-02-17 2019-06-03 Univ Pennsylvania Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
US20140162319A2 (en) * 2012-05-02 2014-06-12 Sangeetha Hareendran Nucleotide sequences, methods, kit and a recombinant cell thereof
US11136557B2 (en) * 2013-05-31 2021-10-05 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
WO2015164757A1 (en) * 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
BR112018003665A2 (en) * 2015-09-28 2018-09-25 The University Of North Carolina At Chapel Hill methods and compositions for antibody evasion viral vectors
FI3445773T3 (fi) * 2016-05-13 2023-03-30 4D Molecular Therapeutics Inc Adenoassosioituneen viruksen kapsidimuunnoksia ja niiden käyttömenetelmiä
BR112020007405A2 (pt) * 2017-10-18 2020-12-08 Regenxbio Inc. Produtos terapêuticos de anticorpo pós-translacionalmente modificados totalmente humanos

Similar Documents

Publication Publication Date Title
JP2021523702A5 (https=)
JP2022068181A5 (https=)
JP2024056895A5 (https=)
JP2022190081A5 (https=)
JP2021118724A5 (https=)
JP2024009857A5 (https=)
JP2018510648A5 (https=)
JP2021514659A5 (https=)
JP2018522529A5 (https=)
JP2021106619A5 (https=)
JP2020519284A5 (https=)
JP2021516046A5 (https=)
EP2660325A3 (en) AAV vectors and corresponding nucleotide sequences and methods
JP2020114235A5 (https=)
JPWO2019168961A5 (https=)
JP2017509632A5 (https=)
IL292264B2 (en) aav transfer cassette
JP2019503649A5 (https=)
JPWO2019213668A5 (https=)
JPWO2020214609A5 (https=)
JPWO2020214613A5 (https=)
JPWO2021222831A5 (https=)
JPWO2021053222A5 (https=)
JPWO2019173538A5 (https=)
JPWO2020168222A5 (https=)